Skip to main content
Caplight Logo









brainQr Therapeutics GmbH

brainQr Therapeutics GmbH

Private
GöttingenHealthcare & Life Scienceshttps://brainqrtherapeutics.com/

Last Round

Accelerator

Aug 15, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

brainQr Therapeutics GmbH is a biotechnology company that develops therapeutic platforms and small-molecule drugs targeting disordered proteins to treat neurodegenerative diseases such as Alzheimer's and Parkinson's.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

drug discoveryintrinsically disordered proteinsIDPsmall-molecule therapeuticsneurodegenerative diseaseAI drug discoverytauopathiesprotein aggregationcomputational biologyin silico drug designbiotech startupdeep learning for biologyAI-first biotechundruggable targetspreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

brainQr Therapeutics GmbH Comparables

Compare brainQr Therapeutics GmbH with similar companies based on industry and business-model similarity.

brainQr Therapeutics GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Topos Bio
89%
Nereid Therapeutics
79%
WaveBreak Therapeutics
78%

brainQr Therapeutics GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 15, 2024
VC RoundAug 15, 2024

brainQr Therapeutics GmbH Investors

Notable investors and investment history

brainQr Therapeutics GmbH investors
InvestorRounds
Life Science Valley WachstumsfondsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors grew 1092% MoM, from 25 to 298.

  • Aug 15, 2024

    Raised a VC Round with Life Science Valley Wachstumsfonds.

brainQr Therapeutics GmbH Filings

Explore SEC and related filing metadata, where available.

brainQr Therapeutics GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about brainQr Therapeutics GmbH's valuation, stock price, and market status.

Is brainQr Therapeutics GmbH a public or private company?

brainQr Therapeutics GmbH is a private company.

What is the current stock price of brainQr Therapeutics GmbH?

brainQr Therapeutics GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is brainQr Therapeutics GmbH worth (valuation)?

Valuation information for brainQr Therapeutics GmbH is not publicly available.

Can I buy brainQr Therapeutics GmbH stock?

brainQr Therapeutics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was brainQr Therapeutics GmbH's last funding round?

brainQr Therapeutics GmbH's most recent funding round was Accelerator on August 15, 2024.

Who are the main investors in brainQr Therapeutics GmbH?

Key investors in brainQr Therapeutics GmbH include Life Science Valley Wachstumsfonds.

Will brainQr Therapeutics GmbH IPO soon?

No public IPO plans have been announced for brainQr Therapeutics GmbH.

How can I track brainQr Therapeutics GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor brainQr Therapeutics GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGöttingen
Employee Range3
Year Founded2024
Last FundingAug 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?